Contineum Therapeutics, Inc. Class A Common Stock
NASDAQ:CTNMBiotechnology
Healthcare
$9.24 -3.20%
-$0.39 today
- Market cap
- $326.66M
- Beta
- 0.89
- P/E (TTM)
- -7.5
- EPS (TTM)
- -$1.57
52W Low $3.69High $16.33
Volume 0.20M
Average 0.26M
Price history
Contineum Therapeutics, Inc. Class A Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-25.66%
Period high
$17.57
Period low
$7.08
Latest
$9.24
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| SC 13G | Nov 5, 2026 | Nov 5, 2026 | |
| 10-Q | Nov 3, 2026 | Nov 3, 2026 | |
| 8-K | Nov 3, 2026 | Nov 3, 2026 | |
| SC 13G | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G/A | Oct 28, 2026 | Oct 28, 2026 | |
| SC 13G | Oct 22, 2026 | Oct 22, 2026 | |
| 8-K | Sep 14, 2026 | Sep 14, 2026 | |
| 4 | Sep 8, 2026 | Sep 8, 2026 | |
| SC 13G/A | Aug 14, 2026 | Aug 14, 2026 | |
| 4 | Aug 3, 2026 | Aug 3, 2026 | |
| 10-Q | Jul 30, 2026 | Jul 30, 2026 | |
| 8-K | Jul 30, 2026 | Jul 30, 2026 | |
| SC 13G | Jul 27, 2026 | Jul 27, 2026 | |
| SC 13G/A | Jul 17, 2026 | Jul 17, 2026 |
Competitors
Who does Contineum Therapeutics, Inc. Class A Common Stock compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about CTNM's filings, answered from its disclosures.
What is the latest CTNM filing?
The latest filing shown is SC 13G/A dated Nov 6, 2026.
How many recent filings does CTNM have?
Intrinsic Alpha currently shows 20 recent filings for CTNM.
Continue the stock analysis
Jump to another research area for this company.